{"id":7219,"date":"2017-03-24T14:02:41","date_gmt":"2017-03-24T14:02:41","guid":{"rendered":"http:\/\/fefac.cat\/empresarial\/?p=7219"},"modified":"2017-03-24T14:02:41","modified_gmt":"2017-03-24T14:02:41","slug":"el-80-dels-pacients-a-favor-daccedir-als-frmac","status":"publish","type":"post","link":"https:\/\/fefac.cat\/empresarial\/el-80-dels-pacients-a-favor-daccedir-als-frmac\/","title":{"rendered":"El 80% dels pacients, a favor d\u2019accedir als f\u00e0rmacs hospitalaris a trav\u00e9s de l\u2019oficina de farm\u00e0cia"},"content":{"rendered":"<p>Durant Infarma s&rsquo;han presentat els resultats preliminars d&rsquo;un estudi realitzat pel F&ograve;rum Espanyol de Pacients i impulsat pels Col&middot;legis de Farmac&egrave;utics de Barcelona i Madrid, que revela que el 80% dels pacients voldrien accedir als medicaments hospitalaris a trav&eacute;s de la farm&agrave;cia comunit&agrave;ria.<\/p>\n<p>L&#39;estudi es compon de dues parts: una quantitativa a trav&eacute;s d&#39;una enquesta online, que han respost un total de 433 persones; i una qualitativa, amb la participaci&oacute; de nou associacions de pacients i amb les que es pretenia aprofundir m&eacute;s en diferents aspectes.<\/p>\n<p>La import&agrave;ncia dels diferents serveis va ser puntuada entre un 3,3 i un 4,1 (sobre 5), sent el m&eacute;s valorat la dispensaci&oacute; a la farm&agrave;cia de medicaments hospitalaris, a m&eacute;s del seguiment farmacoterap&egrave;utic i de detecci&oacute; preco&ccedil; de malalties, com c&agrave;ncer de c&ograve;lon, VIH o risc cardiovascular, aix&iacute; com mesurament de par&agrave;metres biom&egrave;dics.<\/p>\n<p>D&#39;altra banda, els pacients perceben el farmac&egrave;utic com la principal font d&#39;informaci&oacute; sobre l&#39;exist&egrave;ncia d&#39;aquests serveis i acostuma a ser el professional m&eacute;s consultat en temes de medicaments i salut, despr&eacute;s del metge.<\/p>\n<p>Els enquestats tamb&eacute; han destacat que caldria que les farm&agrave;cies disposessin d&rsquo;espais adaptats per millorar la intimitat dels pacients i que seria positiu que hi hagu&eacute;s farm&agrave;cies especialitzades per patologies. Aix&iacute; mateix, han assenyalat que voldrien que s&rsquo;ofer&iacute;s un servei de seguiment de la medicaci&oacute; via telef&ograve;nica despr&eacute;s de la dispensaci&oacute;.<\/p>\n<p>&quot;Necessitem els farmac&egrave;utics prop del pacient, no nom&eacute;s en la dispensaci&oacute;, sin&oacute; tamb&eacute; per acompanyar-lo en l&#39;adher&egrave;ncia&quot;, va afirmar Santiago Alfonso, vicepresident del F&ograve;rum Espanyol de Pacients. &quot;Una de les conclusions clares d&#39;aquest aquest estudi &eacute;s que el pacient confia en el seu farmac&egrave;utic&quot;, va afegir.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Durant Infarma s&rsquo;han presentat els resultats preliminars d&rsquo;un estudi realitzat pel F&ograve;rum Espanyol de Pacients i impulsat pels Col&middot;legis de Farmac&egrave;utics de Barcelona i Madrid, que revela que el 80% [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[11,12,13,14,15,19],"tags":[248,254,276],"class_list":["post-7219","post","type-post","status-publish","format-standard","hentry","category-fefac","category-afb","category-afet","category-afell","category-agfe","category-professio","tag-infarma","tag-medicaments-hospitalaris","tag-mhda"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>El 80% dels pacients, a favor d\u2019accedir als f\u00e0rmacs hospitalaris a trav\u00e9s de l\u2019oficina de farm\u00e0cia - FEFAC<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/fefac.cat\/empresarial\/el-80-dels-pacients-a-favor-daccedir-als-frmac\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"El 80% dels pacients, a favor d\u2019accedir als f\u00e0rmacs hospitalaris a trav\u00e9s de l\u2019oficina de farm\u00e0cia - FEFAC\" \/>\n<meta property=\"og:description\" content=\"Durant Infarma s&rsquo;han presentat els resultats preliminars d&rsquo;un estudi realitzat pel F&ograve;rum Espanyol de Pacients i impulsat pels Col&middot;legis de Farmac&egrave;utics de Barcelona i Madrid, que revela que el 80% [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/fefac.cat\/empresarial\/el-80-dels-pacients-a-favor-daccedir-als-frmac\/\" \/>\n<meta property=\"og:site_name\" content=\"FEFAC\" \/>\n<meta property=\"article:published_time\" content=\"2017-03-24T14:02:41+00:00\" \/>\n<meta name=\"author\" content=\"qabh859\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"qabh859\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minuts\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/el-80-dels-pacients-a-favor-daccedir-als-frmac\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/el-80-dels-pacients-a-favor-daccedir-als-frmac\\\/\"},\"author\":{\"name\":\"qabh859\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/#\\\/schema\\\/person\\\/03012b2506772bd65738ce781a3947f7\"},\"headline\":\"El 80% dels pacients, a favor d\u2019accedir als f\u00e0rmacs hospitalaris a trav\u00e9s de l\u2019oficina de farm\u00e0cia\",\"datePublished\":\"2017-03-24T14:02:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/el-80-dels-pacients-a-favor-daccedir-als-frmac\\\/\"},\"wordCount\":382,\"keywords\":[\"Infarma\",\"medicaments hospitalaris\",\"MHDA\"],\"articleSection\":[\"FEFAC\",\"AFB\",\"AFET\",\"AFELL\",\"AGFE\",\"Professi\u00f3\"],\"inLanguage\":\"ca\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/el-80-dels-pacients-a-favor-daccedir-als-frmac\\\/\",\"url\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/el-80-dels-pacients-a-favor-daccedir-als-frmac\\\/\",\"name\":\"El 80% dels pacients, a favor d\u2019accedir als f\u00e0rmacs hospitalaris a trav\u00e9s de l\u2019oficina de farm\u00e0cia - FEFAC\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/#website\"},\"datePublished\":\"2017-03-24T14:02:41+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/#\\\/schema\\\/person\\\/03012b2506772bd65738ce781a3947f7\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/el-80-dels-pacients-a-favor-daccedir-als-frmac\\\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/el-80-dels-pacients-a-favor-daccedir-als-frmac\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/el-80-dels-pacients-a-favor-daccedir-als-frmac\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"El 80% dels pacients, a favor d\u2019accedir als f\u00e0rmacs hospitalaris a trav\u00e9s de l\u2019oficina de farm\u00e0cia\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/#website\",\"url\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/\",\"name\":\"FEFAC\",\"description\":\"Federaci\u00f3 d&#039;Associacions de Farm\u00e0cies de Catalunya\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ca\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/#\\\/schema\\\/person\\\/03012b2506772bd65738ce781a3947f7\",\"name\":\"qabh859\",\"url\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/author\\\/qabh859\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"El 80% dels pacients, a favor d\u2019accedir als f\u00e0rmacs hospitalaris a trav\u00e9s de l\u2019oficina de farm\u00e0cia - FEFAC","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/fefac.cat\/empresarial\/el-80-dels-pacients-a-favor-daccedir-als-frmac\/","og_locale":"ca_ES","og_type":"article","og_title":"El 80% dels pacients, a favor d\u2019accedir als f\u00e0rmacs hospitalaris a trav\u00e9s de l\u2019oficina de farm\u00e0cia - FEFAC","og_description":"Durant Infarma s&rsquo;han presentat els resultats preliminars d&rsquo;un estudi realitzat pel F&ograve;rum Espanyol de Pacients i impulsat pels Col&middot;legis de Farmac&egrave;utics de Barcelona i Madrid, que revela que el 80% [&hellip;]","og_url":"https:\/\/fefac.cat\/empresarial\/el-80-dels-pacients-a-favor-daccedir-als-frmac\/","og_site_name":"FEFAC","article_published_time":"2017-03-24T14:02:41+00:00","author":"qabh859","twitter_card":"summary_large_image","twitter_misc":{"Escrit per":"qabh859","Temps estimat de lectura":"2 minuts"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/fefac.cat\/empresarial\/el-80-dels-pacients-a-favor-daccedir-als-frmac\/#article","isPartOf":{"@id":"https:\/\/fefac.cat\/empresarial\/el-80-dels-pacients-a-favor-daccedir-als-frmac\/"},"author":{"name":"qabh859","@id":"https:\/\/fefac.cat\/empresarial\/#\/schema\/person\/03012b2506772bd65738ce781a3947f7"},"headline":"El 80% dels pacients, a favor d\u2019accedir als f\u00e0rmacs hospitalaris a trav\u00e9s de l\u2019oficina de farm\u00e0cia","datePublished":"2017-03-24T14:02:41+00:00","mainEntityOfPage":{"@id":"https:\/\/fefac.cat\/empresarial\/el-80-dels-pacients-a-favor-daccedir-als-frmac\/"},"wordCount":382,"keywords":["Infarma","medicaments hospitalaris","MHDA"],"articleSection":["FEFAC","AFB","AFET","AFELL","AGFE","Professi\u00f3"],"inLanguage":"ca"},{"@type":"WebPage","@id":"https:\/\/fefac.cat\/empresarial\/el-80-dels-pacients-a-favor-daccedir-als-frmac\/","url":"https:\/\/fefac.cat\/empresarial\/el-80-dels-pacients-a-favor-daccedir-als-frmac\/","name":"El 80% dels pacients, a favor d\u2019accedir als f\u00e0rmacs hospitalaris a trav\u00e9s de l\u2019oficina de farm\u00e0cia - FEFAC","isPartOf":{"@id":"https:\/\/fefac.cat\/empresarial\/#website"},"datePublished":"2017-03-24T14:02:41+00:00","author":{"@id":"https:\/\/fefac.cat\/empresarial\/#\/schema\/person\/03012b2506772bd65738ce781a3947f7"},"breadcrumb":{"@id":"https:\/\/fefac.cat\/empresarial\/el-80-dels-pacients-a-favor-daccedir-als-frmac\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/fefac.cat\/empresarial\/el-80-dels-pacients-a-favor-daccedir-als-frmac\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/fefac.cat\/empresarial\/el-80-dels-pacients-a-favor-daccedir-als-frmac\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/fefac.cat\/empresarial\/"},{"@type":"ListItem","position":2,"name":"El 80% dels pacients, a favor d\u2019accedir als f\u00e0rmacs hospitalaris a trav\u00e9s de l\u2019oficina de farm\u00e0cia"}]},{"@type":"WebSite","@id":"https:\/\/fefac.cat\/empresarial\/#website","url":"https:\/\/fefac.cat\/empresarial\/","name":"FEFAC","description":"Federaci\u00f3 d&#039;Associacions de Farm\u00e0cies de Catalunya","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/fefac.cat\/empresarial\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ca"},{"@type":"Person","@id":"https:\/\/fefac.cat\/empresarial\/#\/schema\/person\/03012b2506772bd65738ce781a3947f7","name":"qabh859","url":"https:\/\/fefac.cat\/empresarial\/author\/qabh859\/"}]}},"_links":{"self":[{"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/posts\/7219","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/comments?post=7219"}],"version-history":[{"count":0,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/posts\/7219\/revisions"}],"wp:attachment":[{"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/media?parent=7219"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/categories?post=7219"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/tags?post=7219"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}